BC
NVO

Brookfield Corp’s Novo Nordisk NVO Stock Holding History

Brookfield Corp’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-269,808
Closed -$18.3M – 751
2022
Q4 		$18.3M Buy
+269,808
New +$15.8M 0.07% 99
2022
Q3 		– Sell
-241,036
Closed -$13.4M – 734
2022
Q2 		$13.4M Sell
241,036
-115,256
-32% -$6.4M 0.06% 114
2022
Q1 		$19.8M Buy
+356,292
New +$18.3M 0.07% 96
2021
Q4 		– Sell
-117,278
Closed -$5.63M – 711
2021
Q3 		$5.63M Buy
117,278
+69,542
+146% +$3.36M 0.02% 202
2021
Q2 		$2M Sell
47,736
-42,024
-47% -$1.63M 0.01% 355
2021
Q1 		$3.03M Buy
+89,760
New +$3.2M 0.01% 230

Other funds holding NVO

Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return